Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Gene expression profiling of parental and TAMR MCF7 cells after knock-down of ER or FOXA1 or overexpresion of FOXA1
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
FOXA1 overexpression mediates endocrine resistance by increasing IL-8 in oestrogen receptor-positive breast cancer
PubMed Full text in PMC Similar studies
Gene expression profiling of tamoxifen-resistant breast cancer MCF7L cells
CHIP-SEQ of FOXA1 in parental MCF7 cells and tamoxifen resistant MCF7 cells
PubMed Full text in PMC Similar studies SRA Run Selector
Comparative cistromics reveals genomic crosstalk between FOXA1 and ERα in tamoxifen-associated endometrial carcinomas
PubMed Similar studies SRA Run Selector
FoxA1 is a critical determinant of Estrogen Receptor function and endocrine response
PubMed Full text in PMC Similar studies Analyze with GEO2R
FoxA1 is a critical determinant of Estrogen Receptor function and endocrine response (part II)
FoxA1 is a critical determinant of Estrogen Receptor function and endocrine response (part I)
Characterization of FOXA1 mutations in breast cancer
HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
FOXA1 actively represses the molecular phenotype of basal breast cancers.
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq]
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [ChIP-seq]
GATA3 mutation disrupts functional network governed by Estrogen receptor, FOXA1 and GATA3
A class of GATA3 mutation reprograms the breast cancer transcriptional network through gain and loss of function
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
FOXA1 Shapes the Chromatin State of ILC and Drives Differential Response to Aromatase Inhibitors and Tamoxifen [WGS]
Chromatin Accessibility differentiates Invasive Lobular from Invasive Ductal Breast cancer and Dictates Response to Endocrine Treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on